Identification of transcriptomic determinants to predict the efficacy of anti-EGFR treatment of colorectal cancer patients.

被引：0
|
作者：
Chowdhury, Saikat [1 ]
Shen, John Paul Y. C. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期
关键词：
D O I：
10.1200/JCO.2021.39.3_suppl.130
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Optimizing Anti-EGFR Strategies in Cancer Treatment
    Toschi, Luca
    Finocchiaro, Giovanna
    Garassino, Isabella
    De Vincenzo, Fabio
    Campagnoli, Elisabetta
    Ceresoli, Giovanni Luca
    Cavina, Raffaele
    Zucali, Paolo Andrea
    Santoro, Armando
    Cappuzzo, Federico
    CURRENT CANCER THERAPY REVIEWS, 2007, 3 (04) : 267 - 275
  • [42] SERS characterization of colorectal cancer cell surface markers upon anti-EGFR treatment
    Lyu, Nana
    Pedersen, Bernadette
    Shklovskaya, Elena
    Rizos, Helen
    Molloy, Mark P.
    Wang, Yuling
    EXPLORATION, 2022, 2 (03):
  • [43] Impact of genetic profiles on the efficacy of anti-EGFR antibodies in metastatic colorectal cancer with KRAS mutation
    Kishiki, Tomokazu
    Ohnishi, Hiroaki
    Masaki, Tadahiko
    Ohtsuka, Kouki
    Ohkura, Yasuo
    Furuse, Jyunji
    Sugiyama, Masanori
    Watanabe, Takashi
    ONCOLOGY REPORTS, 2014, 32 (01) : 57 - 64
  • [44] Efficacy of BRAF inhibitor and anti-EGFR antibody in colorectal neuroendocrine carcinoma
    Mae Nakano
    Yoshifumi Shimada
    Yoshifumi Matsumoto
    Takuro Saiki
    Qiliang Zhou
    Kenta Sasaki
    Masato Moriyama
    Kosuke Yoshihara
    Manabu Natsumeda
    Yoko Kuriyama
    Yasumasa Takii
    Gen Watanabe
    Hajime Umezu
    Shujiro Okuda
    Takeshi Ikeuchi
    Toshifumi Wakai
    Yasuo Saijo
    Clinical Journal of Gastroenterology, 2022, 15 : 413 - 418
  • [45] Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial Origin
    Zaanan, Aziz
    Henriques, Julie
    Cohen, Romain
    Sefrioui, David
    Evrard, Camille
    de la Fouchardiere, Christelle
    Lecomte, Thierry
    Aparicio, Thomas
    Svrcek, Magali
    Taieb, Julien
    Andre, Thierry
    Vernerey, Dewi
    Tougeron, David
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (04): : 496 - 500
  • [46] Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer
    Masahiro Inoue
    Shin Takahashi
    Hiroshi Soeda
    Hideki Shimodaira
    Mika Watanabe
    Koh Miura
    Iwao Sasaki
    Shunsuke Kato
    Chikashi Ishioka
    International Journal of Clinical Oncology, 2015, 20 : 1147 - 1155
  • [47] Efficacy of BRAF inhibitor and anti-EGFR antibody in colorectal neuroendocrine carcinoma
    Nakano, Mae
    Shimada, Yoshifumi
    Matsumoto, Yoshifumi
    Saiki, Takuro
    Zhou, Qiliang
    Sasaki, Kenta
    Moriyama, Masato
    Yoshihara, Kosuke
    Natsumeda, Manabu
    Kuriyama, Yoko
    Takii, Yasumasa
    Watanabe, Gen
    Umezu, Hajime
    Okuda, Shujiro
    Ikeuchi, Takeshi
    Wakai, Toshifumi
    Saijo, Yasuo
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2022, 15 (02) : 413 - 418
  • [48] Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer
    Inoue, Masahiro
    Takahashi, Shin
    Soeda, Hiroshi
    Shimodaira, Hideki
    Watanabe, Mika
    Miura, Koh
    Sasaki, Iwao
    Kato, Shunsuke
    Ishioka, Chikashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (06) : 1147 - 1155
  • [49] Anti-EGFR therapy in first-line colorectal cancer
    Lamas, Maria J.
    Duran, Goretti
    Gallardo, Elena
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (10) : 1499 - 1503
  • [50] Current concepts of anti-EGFR targeting in metastatic colorectal cancer
    Doleschal, Bernhard
    Petzer, Andreas
    Rumpold, Holger
    FRONTIERS IN ONCOLOGY, 2022, 12
12345